The American Journal of Medicine
Volume 119, Issue 8 , Pages 693-699, August 2006

A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness

  • Salah Gariballa, MD

      Affiliations

    • Sheffield Institute for Studies on Ageing, University of Sheffield, United Kingdom
    • Department of Internal Medicine, UAE University, United Arab Emirate
    • Corresponding Author InformationRequests for reprints should be addressed to Salah Gariballa, Department of Internal Medicine, Faculty of Medicine and Health Sciences, UAE University, United Arab Emirate
  • ,
  • Sarah Forster, MSc

      Affiliations

    • Sheffield Institute for Studies on Ageing, University of Sheffield, United Kingdom
  • ,
  • Stephen Walters, PhD

      Affiliations

    • Medical Statistics, ScHARR, University of Sheffield, United Kingdom
  • ,
  • Hilary Powers, PhD

      Affiliations

    • Human Nutrition Unit, University of Sheffield, United Kingdom

Abstract 

Purpose

The study tested whether nutritional support of older patients during acute illness leads to a clinical benefit.

Methods

In this randomized, double-blind, placebo-controlled study, we randomly assigned 445 hospitalized patients aged 65 to 92 years to receive either a normal hospital diet plus 400 mL oral nutritional supplements (223 subjects) or a normal hospital diet plus a placebo (222 subjects) daily for 6 weeks. The composition of the supplement was such as to provide 995 kcal of energy and 100% of the Reference Nutrient Intakes for vitamins and minerals for a healthy older person. Patients had three assessments: at baseline, at 6 weeks, and at 6 months post-randomization. Outcome measures were 6 months of disability, non-elective readmission and length of hospital stay, discharge destination, morbidity, and mortality.

Results

Randomization to the supplement group led to a significant improvement in nutritional status. Over 6 months, 65 patients (29%) in the supplements group were readmitted to the hospital compared with 89 patients (40%) in the placebo group (adjusted hazard ratio 0.68 [95% confidence interval 0.49-0.94]). The mean length of hospital stay was 9.4 days in the supplements group compared with 10.1 days in the placebo group. Thirty-two people (14%) died in the supplement group compared with 19 people (9%) in the placebo group at 6 months (adjusted hazard ratio 1.65 [95% confidence interval, 0.93-2.92]).

Conclusion

Oral nutritional supplementation of acutely ill patients improved nutritional status and led to a statistically significant reduction in the number of non-elective readmissions.

Keywords: Nutritional supplements, Acute illness, Clinical outcome, Readmission

 

PII: S0002-9343(05)01153-8

doi:10.1016/j.amjmed.2005.12.006

The American Journal of Medicine
Volume 119, Issue 8 , Pages 693-699, August 2006